AION Labs Launches Seeding Track with Promise Bio

AION Lab’s Promise Bio included in The 51 most disruptive startups of 2024

Promise Bio secures $8.3M in seed investment for immune-mediated diseases

Promise Bio raises $8.3 million in Seed funding for its precision medicine tool for diseases

AION Labs introduces AI startup to hasten identification of active small molecules

AION Labs Exploring Clinical Trials to Build New Start-up

Meet Dr. Sharon Kredo-Rousso, AION Labs VP Ideation

Sharon Gour-Arie joins AION Labs as VP Value Creation

In Israel, Big Pharma & Innovators Are Using Tech To Fight Disease

Israeli startup to use AI to transform antibody discovery, design